Reporter Feb 25 2022
Probing cancer cell invasion
Mar. 1, 2022—The rigidity of the extracellular matrix that surrounds cells impacts the contractile and invasive properties of head and neck cancer cells.
Invasive strep can defy zinc toxicity
Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
PET imaging probe for Alzheimer’s disease
Feb. 24, 2022—Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.
Melanoma treatment response
Feb. 24, 2022—Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found.
Ahonkhai advances in national challenge to improve HIV care for Black men in Tennessee
Feb. 24, 2022—A Vanderbilt proposal to implement a novel strategy to use barbers and barbershops to improve HIV care outcomes for Black men with HIV in Middle Tennessee received early-stage funding from a challenge hosted by the U.S. Department of Health and Human Services’ Office of Minority Health.
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
Feb. 24, 2022—A Vanderbiltl study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).
Capacity building activities and new curriculum strengthen medical education in Liberia
Feb. 24, 2022—Liberia's fragile health system is being strengthened through U.S.-Liberia partnerships focused on medical education and capacity building at the country's only medical school, A.M. Dogliotti (AMD) School of Medicine in the College of Health Sciences at the University of Liberia.
Spinal cord stimulator implants helping ease chronic pain
Feb. 24, 2022—Specialists at Vanderbilt University Medical Center implanted 130 spinal cord stimulators last year to help ease patients' chronic pain.
VUMC researchers find clue to drug-induced arrhythmias
Feb. 24, 2022—Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.
Heart/liver transplant gives congenital heart disease patient new hope
Feb. 24, 2022—Last year, Liz Barnett became one of seven people at Vanderbilt University Medical Center to receive a combined heart/liver transplant in 2021.
Study to explore neurologic impact of flu treatment
Feb. 24, 2022—A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.
VUMC’s Smith elected to AIMBE College of Fellows
Feb. 24, 2022—Vanderbilt's Seth Smith, PhD, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering.
